Multi-omics and bioinformatics pipelines for personalized neoantigen discovery: current frameworks, challenges, and clinical translation

Information from the abstract

Personalized neoantigen vaccines promise precise cancer immunotherapy, yet identifying immunogenic epitopes remains challenging. This review evaluates bioinformatics and multi-omics pipelines across a four-tier framework: variant-to-candidate prediction, HLA binding and presentation, immunopeptidomics, and proteogenomic integration. We examine MHC-II modeling, long-read sequencing, and TCR-aware architectures while addressing biological bottlenecks, such as tumor heterogeneity and immune evasion, to accelerate the development and clinical translation of robust, personalized cancer immunotherapy.

Why this record is monitored

This record has an Impact Signal of 78/100 based on recency, source, collaboration, and bibliographic signals. It prioritizes monitoring and is not a judgment of research quality.

Related topics: vaccines and immunoinformatics approaches · Cancer Immunotherapy and Biomarkers · Immunotherapy and Immune Responses